Premium
Reply to Mini‐HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope?
Author(s) -
Sasaki Koji,
Kantarjian Hagop M.,
Jabbour Elias J.
Publication year - 2019
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.32385
Subject(s) - medicine , blinatumomab , cyclophosphamide , vincristine , regimen , mortality rate , pediatrics , cohort , oncology , chemotherapy , leukemia , lymphoblastic leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom